Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

7,150 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    FDA Announces Grant Funds For Increasing Quality, Efficiency Of Clinical Trials

    FDA announced the availability of grant funds to support the efforts of CDER to increase the quality and efficiency of clinical trials.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Classifies Autosomal Recessive Carrier Screening Gene Mutation Detection System Into Class II

    In the October 27, 2015, Federal Register, FDA issued a final order classifying an autosomal recessive carrier screening gene mutation detection system into class II (special controls).
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
Jones Day
  • Article

    FDA Classifies Dengue Reagents And Pancreatic Stent As Class II With Special Controls

    FDA recently issued final classification orders for dengue virus serological reagents and a pancreatic drainage stent and delivery system.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Classifies Hemoglobin A1c Test System Into Class II

    In the August 25, 2014, Federal Register, FDA classified the hemoglobin A1c test system into class II (special controls).
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Classifies The Esophageal Thermal Regulation Device Into Class II

    In the August 18, 2015, Federal Register, FDA published its classification of the esophageal thermal regulation device into class II (special controls) medical device.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Classifies Two Devices To Treat Headache Into Class II

    The special controls applicable to the device will be part of the codified language for the transcranial magnetic stimulator for headache classification.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Determines LUPRON DEPOT Not Withdrawn For Safety Or Effectiveness Reasons

    FDA published its determination that LUPRON DEPOT, an injectable vial containing 3.75 milligrams of the drug, was not withdrawn from sale for reasons of safety or effectiveness.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Issues Emergency Use Authorization For Ebola IVD

    FDA announced it had issued an Emergency Use Authorization for an in vitro diagnostic device to detect of the Ebola Zaire virus.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Issues EUA For Influenza Test

    FDA announced an Emergency Use Authorization for an in vitro diagnostic device used to detect the novel influenza A virus.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Issues Final Order Classifying Powered Surgical Instruments For Improvement In The Appearance Of Cellulite As Class II With Special Controls

    FDA issued a final order classifying powered surgical instruments for improvement in the appearance of cellulite into Class II with special controls.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Issues Final Order Downclassifying Certain IVDs

    FDA reclassified nucleic acid-based in vitro diagnostic devices for the detection of Mycobacterium tuberculosis complex in respiratory specimens from class III into class II.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Issues Final Rule Establishing List Of Qualifying Pathogens Under FDASIA

    FDA issued a final rule implementing a provision of the Generating Antibiotic Incentives Now title of the Food and Drug Administration Safety and Innovation Act.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Orders Classification Of The Physiologic Simulation Software Device

    In the October 21, 2015, Federal Register, FDA issued an order classifying the coronary vascular physiologic simulation software device into class II (special controls).
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA To Host Clinical Outcome Assessments Public Workshop (April 1)

    On April 1, 2015, the FDA is hosting a workshop entitled "Clinical Outcomes Assessment Development and Implementation: Opportunities and Challenges."
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    House Approves Legislation To Speed Development Of Zika Virus Treatments

    On April 12, 2016, the House of Representatives gave final approval to S. 2512, which would add the Zika virus to the FDA Priority Review Voucher Program that encourages treatments for tropical diseases.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    House Panel To Examine FDA Lab-Developed Test Policy

    On September 9, 2014, the House Energy and Commerce Subcommittee on Health is holding a hearing entitled "21st Century Cures: Examining the Regulation of Laboratory Developed Tests."
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    Key House And Senate Panels Invite Comments On SGR Reform Plan (Due Nov. 12)

    The House Ways and Means and Senate Finance Committees have released the outline of bipartisan, bicameral Medicare physician fee schedule/sustainable growth rate (SGR) formula reform legislation.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    Nov. 10 CMS Call Will Review Clinical Lab Test Payment Proposed Rule

    On November 10, 2015, CMS is hosting a public call to discuss its October 1, 2015 proposed rule that would make significant changes to the Medicare clinical diagnostic laboratory test payment system.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    PA Biotech Center Companies Showcased To Potential Investors At Second Annual ‘Entrepreneur Spotlight'

    Elizabeth D. Sigety was featured in the PR web article, "PA Biotech Center Companies Showcased to Potential Investors at Second Annual ‘Entrepreneur Spotlight.'"
    United StatesFood, Drugs, Healthcare, Life Sciences
    Fox Rothschild LLP
    Fox Rothschild LLP
  • Article

    Physician-Owned Distributor Update

    Our sister blog, Life Sciences Legal Update, reports on recent developments involving the Office of the Inspector General (OIG) scrutiny of physician-owned distributors, including the disposition of a device manufacturer's challenge to a related OIG Fraud Alert.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Showing 21–40 of 7150 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics